Drug Topics
AUGUST 21, 2024
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
Pharmacy Times
AUGUST 23, 2024
The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 23, 2024
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.
Fierce Healthcare
AUGUST 20, 2024
Health IT giant Epic is pushing ahead rapidly to build out artificial intelligence technologies and generative AI features in its electronic health record software. | The goal, according to Epic executives, is to ease the documentation burden for clinicians, streamline charting and coding and bring evidence-based medical insights and research right to doctors' fingertips at the point of care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 19, 2024
The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.
Pharmacy Times
AUGUST 19, 2024
The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
AUGUST 23, 2024
The healthcare industry confronts a complex, double-barreled challenge as it tries to combat the recent deluge of dangerous and damaging cyberattacks. | Cyber resilience is the ability to recognize threats, respond to them, recover quickly and at scale. The clear goal: fending off attacks more efficiently, limiting damage and restoring normal operations with minimal impact to patients.
Drug Topics
AUGUST 23, 2024
Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.
Pharmacy Times
AUGUST 19, 2024
Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.
STAT
AUGUST 19, 2024
Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
AUGUST 20, 2024
Regulators in both the U.S. and Europe have looked into the potential link between suicidal thoughts and Novo Nordisk’s blockbuster semaglutide franchise after reports sounded the alarm last year. | Researchers found that users of Novo's semaglutide who were logged in a WHO database were more likely to report suicidal ideation.
Drug Topics
AUGUST 21, 2024
Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.
Fierce Healthcare
AUGUST 22, 2024
Employers are actively seeking out alternatives to curb rising health benefit costs by sidestepping traditional carriers, a new report from Brighton Health Plan Solutions shows. | A new report highlights a business opportunity for providers and health systems to engage in direct contracting.
STAT
AUGUST 19, 2024
The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can blanket an entire household, burdening spouses and other family members with stress and anxiety and the exhausting routine of treating a life-threatening disease. But while standards exist for assessing and managing distress in patients, it’s often “hidden” in family members, sometimes with devastating
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 18, 2024
Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.
Drug Topics
AUGUST 21, 2024
Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.
Fierce Healthcare
AUGUST 20, 2024
The upward trajectory of Medicare Advantage (MA) enrollment is likely to become an issue for hospitals and other healthcare providers forced to contend with plans’ prior authorization requirements | Prior authorization burdens and "a challenging contract negotiation season" on the horizon are likely headwinds for providers, and hospitals in particular, according to a recent report.
STAT
AUGUST 19, 2024
SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked. The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.
Fierce Pharma
AUGUST 20, 2024
As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem. | As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem.
Drug Topics
AUGUST 21, 2024
A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.
Fierce Healthcare
AUGUST 21, 2024
The Centers for Medicare & Medicaid Services (CMS) issued a new report Tuesday detailing total complaints related to the No Surprises Act and Affordable Care Act compliance. | A new CMS report outlines the types of No Surprises Act complaints resolved by the federal agency since June 30.
STAT
AUGUST 17, 2024
It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic stress disorder developed by Lykos Therapeutics, a company that he founded. The next day, the journal Psychopharmacology retracted three studies on the treatment, in which many authors were associated with Lykos or the nonprofit Doblin founded, the Multidisciplinary Association for Psychedelic Studies (MAPS).
pharmaphorum
AUGUST 21, 2024
Demonstrating EVERSANA's dedication to innovation, a novel artificial intelligence technology is set to enhance the NAVLIN experience for both current and prospective customers.
Drug Topics
AUGUST 21, 2024
The National Association of Chain Drug Stores is active at both the federal and state levels in advocating for PBM reform.
Fierce Healthcare
AUGUST 20, 2024
Employers are up against escalating healthcare costs, driven by mounting prescription drug expenses, inflation and worsening chronic conditions, a new survey shows. | Employers are up against escalating healthcare costs, driven by mounting prescription drug expenses, inflation and worsening chronic conditions, a new survey shows.
STAT
AUGUST 22, 2024
WASHINGTON — U.S. regulators approved updated Covid-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.
BioPharm
AUGUST 21, 2024
Under a deal worth potentially up to $1.3 billion, Merck, known as MSD outside of the United States and Canada, will acquire CN201, a next-generation bispecific antibody, from Curon Biopharmaceutical.
Drug Topics
AUGUST 22, 2024
Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.
Fierce Healthcare
AUGUST 21, 2024
A Texas federal judge has struck down the Federal Trade Commission’s rule broadly banning employers’ noncompete agreements 15 days before it was set to go into effect nationwide. | U.S. District Judge Ada Brown ruled that the FTC exceeded its statutory authority and failed to present sufficient evidence for its sweeping ban. Mixed rulings among other district courts and comments from a regulator spokesperson suggest an appeal is likely.
STAT
AUGUST 22, 2024
If you’d told Jim Wilson three years ago that he’d be stepping down as director of the University of Pennsylvania’s storied Gene Therapy Program, he wouldn’t have believed you. And yet he’s now doing exactly that. Wilson, a gene therapy pioneer who has spent decades devising ways to deliver functional copies of missing or defective genes to patients, recently announced that he’s leaving Penn to found a pair of companies focused on developing gene therapi
Fierce Pharma
AUGUST 23, 2024
Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.
Drug Topics
AUGUST 23, 2024
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the importance of cooling medications in the rising heat of the summer months.
Fierce Healthcare
AUGUST 22, 2024
A Thursday afternoon sale hearing scheduled for several Steward Health Care hospitals was shelved in favor of an amended bankruptcy court itinerary hashing out multiple disputes related to the comp | A busy day in bankruptcy court brought new updates on Steward Health Care's bids and closure plans for hospitals in Florida, Pennsylvania and Massachusetts.
STAT
AUGUST 20, 2024
Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In a Phase 3 trial that lasted over three years, people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to diabetes compared with people on placebo, Lilly said Tuesday.
Expert insights. Personalized for you.
112 
Let's personalize your content